{"transactions":[{"id":4618103,"issuer":{"id":6454,"kind":"organization","name":"Conexeu Sciences Inc.","symbol":"CNXU"},"owners":[{"id":44311,"kind":"person","name":"Sharpe Jeffrey Nathan","position":1,"cik":"0002127816","reported_name":"Sharpe Jeffrey Nathan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Performance Warrants","published_at":"2026-09-15T20:30:16.000Z","date":"2026-09-14","kind":"exercise","planned":false,"acquired":false,"shares":500000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction is also exempt from Section 16(b) of the Securities Exchange Act of 1934, as amended (the \"Act\") pursuant to Rule 16b-6(b) promulgated under the Act."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Performance Warrants were granted on June 5, 2025 and have an exercise price of $0.001 and a term of 5 years. The Performance Warrants were granted for services rendered to the issuer and no price was paid for the Performance Warrants. The Performance Warrants will vest and be exercisable upon the following milestone events: (i) 500,000 Performance Warrants upon the Issuer's listed shares of common stock trading for at least 20 consecutive trading days at a market capitalization of $80,000,000 or greater in the currency of the recognized stock exchange in North America on which the shares of common stock are listed, which have vested; and (ii) 500,000 Performance Warrants upon the Issuer submitting a 510(k) application to the United States Food and Drug Administration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Performance Warrants were granted on June 5, 2025 and have an exercise price of $0.001 and a term of 5 years. The Performance Warrants were granted for services rendered to the issuer and no price was paid for the Performance Warrants. The Performance Warrants will vest and be exercisable upon the following milestone events: (i) 500,000 Performance Warrants upon the Issuer's listed shares of common stock trading for at least 20 consecutive trading days at a market capitalization of $80,000,000 or greater in the currency of the recognized stock exchange in North America on which the shares of common stock are listed, which have vested; and (ii) 500,000 Performance Warrants upon the Issuer submitting a 510(k) application to the United States Food and Drug Administration."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The Performance Warrants were granted on June 5, 2025 and have an exercise price of $0.001 and a term of 5 years. The Performance Warrants were granted for services rendered to the issuer and no price was paid for the Performance Warrants. The Performance Warrants will vest and be exercisable upon the following milestone events: (i) 500,000 Performance Warrants upon the Issuer's listed shares of common stock trading for at least 20 consecutive trading days at a market capitalization of $80,000,000 or greater in the currency of the recognized stock exchange in North America on which the shares of common stock are listed, which have vested; and (ii) 500,000 Performance Warrants upon the Issuer submitting a 510(k) application to the United States Food and Drug Administration."}],"balance_after":500000,"derivative":{"exercise_price":0.001,"expiration_date":"2030-06-05","underlying":"Common Stock","underlying_shares":500000},"source":{"system":"sec-edgar","filing":"0001062993-26-004966","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2127816/000106299326004966/form4.xml","form_type":"4"}},{"id":4618102,"issuer":{"id":6454,"kind":"organization","name":"Conexeu Sciences Inc.","symbol":"CNXU"},"owners":[{"id":44311,"kind":"person","name":"Sharpe Jeffrey Nathan","position":1,"cik":"0002127816","reported_name":"Sharpe Jeffrey Nathan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-09-15T20:30:16.000Z","date":"2026-09-14","kind":"exercise","planned":false,"acquired":true,"shares":500000,"price":0.001,"value":500.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction is also exempt from Section 16(b) of the Securities Exchange Act of 1934, as amended (the \"Act\") pursuant to Rule 16b-6(b) promulgated under the Act."}],"balance_after":1500000,"source":{"system":"sec-edgar","filing":"0001062993-26-004966","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2127816/000106299326004966/form4.xml","form_type":"4"}},{"id":764165,"issuer":{"id":6454,"kind":"organization","name":"Conexeu Sciences Inc.","symbol":"CNXU"},"owners":[{"id":44311,"kind":"person","name":"Sharpe Jeffrey Nathan","position":1,"cik":"0002127816","reported_name":"Sharpe Jeffrey Nathan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Performance Warrants","published_at":"2026-05-26T10:16:20.000Z","date":"2026-05-22","kind":"exercise","planned":false,"acquired":false,"shares":500000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction is also exempt from Section 16(b) of the Securities Exchange Act of 1934, as amended (the \"Act\") pursuant to Rule 16b-6(b) promulgated under the Act."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Performance Warrants were granted on June 5, 2025 and have an exercise price of $0.001 and a term of 5 years. The Performance Warrants were granted for services rendered to the issuer and no price was paid for the Performance Warrants. The Performance Warrants will vest and be exercisable upon the following milestone events: (i) 500,000 Performance Warrants upon the Issuer's shares of common stock being listed on a recognized stock exchange in North America, which have vested; (ii) 500,000 Performance Warrants upon the Issuer's listed shares of common stock trading for at least 20 consecutive trading days at a market capitalization of $80,000,000 or greater in the currency of the recognized stock exchange in North America on which the shares of common stock are listed; and (iii) 500,000 Performance Warrants upon the Issuer submitting a 510(k) application to the United States Food and Drug Administration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Performance Warrants were granted on June 5, 2025 and have an exercise price of $0.001 and a term of 5 years. The Performance Warrants were granted for services rendered to the issuer and no price was paid for the Performance Warrants. The Performance Warrants will vest and be exercisable upon the following milestone events: (i) 500,000 Performance Warrants upon the Issuer's shares of common stock being listed on a recognized stock exchange in North America, which have vested; (ii) 500,000 Performance Warrants upon the Issuer's listed shares of common stock trading for at least 20 consecutive trading days at a market capitalization of $80,000,000 or greater in the currency of the recognized stock exchange in North America on which the shares of common stock are listed; and (iii) 500,000 Performance Warrants upon the Issuer submitting a 510(k) application to the United States Food and Drug Administration."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The Performance Warrants were granted on June 5, 2025 and have an exercise price of $0.001 and a term of 5 years. The Performance Warrants were granted for services rendered to the issuer and no price was paid for the Performance Warrants. The Performance Warrants will vest and be exercisable upon the following milestone events: (i) 500,000 Performance Warrants upon the Issuer's shares of common stock being listed on a recognized stock exchange in North America, which have vested; (ii) 500,000 Performance Warrants upon the Issuer's listed shares of common stock trading for at least 20 consecutive trading days at a market capitalization of $80,000,000 or greater in the currency of the recognized stock exchange in North America on which the shares of common stock are listed; and (iii) 500,000 Performance Warrants upon the Issuer submitting a 510(k) application to the United States Food and Drug Administration."}],"balance_after":1000000,"derivative":{"exercise_price":0.001,"expiration_date":"2030-06-05","underlying":"Common Stock","underlying_shares":500000},"source":{"system":"sec-edgar","filing":"0001062993-26-002870","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2066836/000106299326002870/form4.xml","form_type":"4"}},{"id":764164,"issuer":{"id":6454,"kind":"organization","name":"Conexeu Sciences Inc.","symbol":"CNXU"},"owners":[{"id":44311,"kind":"person","name":"Sharpe Jeffrey Nathan","position":1,"cik":"0002127816","reported_name":"Sharpe Jeffrey Nathan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-26T10:16:20.000Z","date":"2026-05-22","kind":"exercise","planned":false,"acquired":true,"shares":500000,"price":0.001,"value":500.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction is also exempt from Section 16(b) of the Securities Exchange Act of 1934, as amended (the \"Act\") pursuant to Rule 16b-6(b) promulgated under the Act."}],"balance_after":1000000,"source":{"system":"sec-edgar","filing":"0001062993-26-002870","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2066836/000106299326002870/form4.xml","form_type":"4"}}]}